Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes. METHODS AND FINDINGS: We searched the PubMed, EMBASE, Latin American and Caribbean Health Sciences Literature (LILACS), Indian Medlars Centre (IndMed) and African Index Medicus (AIM) databases and the abstracts of three conferences for studies that traced patients lost to follow up to ascertain their vital status. Main outcomes were the proportion of patients traced, the proportion found to be alive and the proportion that had died. Where available, we also examined the reasons why some patients could not be traced, why patients found to be alive did not return to the clinic, and the causes of death. We combined mortality data from several studies using random-effects meta-analysis. Seventeen studies were eligible. All were from sub-Saharan Africa, except one study from India, and none were conducted in children. A total of 6420 patients (range 44 to 1343 patients) were included. Patients were traced using telephone calls, home visits and through social networks. Overall the vital status of 4021 patients could be ascertained (63%, range across studies: 45% to 86%); 1602 patients had died. The combined mortality was 40% (95% confidence interval 33%-48%), with substantial heterogeneity between studies (P<0.0001). Mortality in African programmes ranged from 12% to 87% of patients lost to follow-up. Mortality was inversely associated with the rate of loss to follow up in the programme: it declined from around 60% to 20% as the percentage of patients lost to the programme increased from 5% to 50%. Among patients not found, telephone numbers and addresses were frequently incorrect or missing. Common reasons for not returning to the clinic were transfer to another programme, financial problems and improving or deteriorating health. Causes of death were available for 47 deaths: 29 (62%) died of an AIDS defining illness. CONCLUSIONS: In ART programmes in resource-limited settings a substantial minority of adults lost to follow up cannot be traced, and among those traced 20% to 60% had died. Our findings have implications both for patient care and the monitoring and evaluation of programmes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Stringer, J. S. A., Zulu, I., Levy, J., Stringer, E. M., Mwango, A., Chi, B. H., Mtonga, V., Reid, S., Cantrell, R. A., Bulterys, M., et al. (2006) · JAMA · doi:10.1001/jama.296.7.782 · Cited by 655
Egger, M., Hirschel, B., Francioli, P., Sudre, P., Wirz, M., Flepp, M., Rickenbach, M., Malinverni, R., Vernazza, P., & Battegay, M. (1997) · BMJ · doi:10.1136/bmj.315.7117.1194 · Cited by 615
Self-citationHunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa
Hardon, A. P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H. F., Gerrits, T., Kglatwane, J., Kinsman, J., Kwasa, R., Maridadi, J., et al. (2007) · AIDS Care · doi:10.1080/09540120701244943 · Cited by 497
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana
Weiser, S., Wolfe, W., Bangsberg, D., Thior, I., Gilbert, P., Makhema, J., Kebaabetswe, P., Dickenson, D., Mompati, K., Essex, M., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200311010-00004 · Cited by 473
Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., Caputo, S. L., Narciso, P., Pauluzzi, S., Carosi, G., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200112150-00006 · Cited by 473
Cited by
Lester, R. T., Ritvo, P., Mills, E. J., Kariri, A., Karanja, S., Chung, M. H., Jack, W., Habyarimana, J., Sadatsafavi, M., Najafzadeh, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61997-6 · Cited by 1,278
Fox, M. P., & Rosen, S. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02508.x · Cited by 559
Johnson, L. F., Mossong, J., Dorrington, R. E., Schomaker, M., Hoffmann, C. J., Keiser, O., Fox, M. P., Wood, R., Prozesky, H., Giddy, J., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001418 · Cited by 437
Self-citationMills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., Nachega, J. B., Dybul, M., & Hogg, R. S. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-4-201108160-00358 · Cited by 415
Wandeler, G., Johnson, L. F., & Egger, M. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000298 · Cited by 399
Self-citationAkl, E. A., Briel, M., You, J. J., Sun, X., Johnston, B. C., Busse, J. W., Mulla, S., Lamontagne, F., Bassler, D., Vera, C., et al. (2012) · BMJ · doi:10.1136/bmj.e2809 · Cited by 350
Kranzer, K., Govindasamy, D., Ford, N., Johnston, V., & Lawn, S. D. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17383 · Cited by 306
Geng, E. H., Bangsberg, D. R., Musinguzi, N., Emenyonu, N., Bwana, M. B., Yiannoutsos, C. T., Glidden, D. V., Deeks, S. G., & Martin, J. N. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b843f0 · Cited by 300
Geng, E. H., Nash, D., Kambugu, A., Zhang, Y., Braitstein, P., Christopoulos, K. A., Muyindike, W., Bwana, M. B., Yiannoutsos, C. T., Petersen, M. L., et al. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0061-5 · Cited by 282
Jani, I. V., Sitoe, N. E., Alfai, E. R., Chongo, P. L., Quevedo, J. I., Rocha, B. M., Lehe, J. D., & Peter, T. F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61052-0 · Cited by 264
Egger, M., Ekouevi, D. K., Williams, C., Lyamuya, R. E., Mukumbi, H., Braitstein, P., Hartwell, T., Graber, C., Chi, B. H., Boulle, A., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr080 · Cited by 257
Self-citationMay, M., Boulle, A., Phiri, S., Messou, E., Myer, L., Wood, R., Keiser, O., Sterne, J. A., Dabis, F., & Egger, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60666-6 · Cited by 250
Self-citationCornell, M., Schomaker, M., Garone, D. B., Giddy, J., Hoffmann, C. J., Lessells, R., Maskew, M., Prozesky, H., Wood, R., Johnson, L. F., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001304 · Cited by 244
“Given that a high proportion of patients LTF are likely to have died [13], we used inverse probability weighting [22] to correct mortality and LTF for missing deaths among those defined as LTF.”
BackgroundMethodSelf-citationCornell, M., Grimsrud, A., Fairall, L., Fox, M. P., van Cutsem, G., Giddy, J., Wood, R., Prozesky, H., Mohapi, L., Graber, C., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833d45c5 · Cited by 223
“lost to care) as well as those classified LTFU through administrative error or inadequate patient monitoring systems [15,24].”
BackgroundSelf-citationAuld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1489-0 · Cited by 14
Metadata
- Authors
- Brinkhof, M. W. G., Pujades-Rodriguez, M., & Egger, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-04
- Volume
- 4
- Issue
- 6
- Pages
- e5790
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2031368727
- Cited by
- 482
- References
- 27
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.